1. Home
  2. NXST vs MIRM Comparison

NXST vs MIRM Comparison

Compare NXST & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nexstar Media Group Inc.

NXST

Nexstar Media Group Inc.

HOLD

Current Price

$230.16

Market Cap

6.4B

Sector

Industrials

ML Signal

HOLD

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$93.20

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NXST
MIRM
Founded
1996
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4B
5.4B
IPO Year
2002
2019

Fundamental Metrics

Financial Performance
Metric
NXST
MIRM
Price
$230.16
$93.20
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
12
Target Price
$264.43
$114.67
AVG Volume (30 Days)
260.2K
702.8K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
3.25%
N/A
EPS Growth
N/A
74.59
EPS
3.00
N/A
Revenue
$4,949,000,000.00
$19,138,000.00
Revenue This Year
$11.56
$26.22
Revenue Next Year
N/A
$21.77
P/E Ratio
$76.43
N/A
Revenue Growth
N/A
N/A
52 Week Low
$141.66
$36.88
52 Week High
$254.30
$109.28

Technical Indicators

Market Signals
Indicator
NXST
MIRM
Relative Strength Index (RSI) 43.86 46.75
Support Level $182.70 $72.17
Resistance Level $254.13 $107.51
Average True Range (ATR) 8.17 4.02
MACD -2.61 -0.03
Stochastic Oscillator 2.10 56.11

Price Performance

Historical Comparison
NXST
MIRM

About NXST Nexstar Media Group Inc.

Nexstar is the largest television station owner-operator in the United States with over 200 stations in 116 markets, reaching 220 million people. Of its 200 stations, 155 are affiliated with the four national broadcast networks: CBS, Fox, NBC, and ABC. Pending approval, Nexstar's merger with Tegna would bring Nexstar's station total to 259 in 133 markets, reaching 80% of the US population. Nexstar also owns NewsNation (formerly WGN), a cable news network, 75% of the fifth national broadcaster, the CW, and a 31% stake in Food Network and Cooking Channel.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: